Magnendo closed $18 million Series A led by Penumbra to advance its magnetic robotic navigation platform toward first-in-human clinical studies for endovascular stroke treatment.
- Amount
- $18M
- Stage
- Series A
- Announced
- 24 July 2026
- Lead
- Penumbra, Inc.
- Use of funds
- Productize its robotic platform and magnetic guidewires and prepare for first-in-human clinical studies.
- Checked
- Matched to an official SEC filing